Insider Transactions Reported by 11 Insiders of Dare Bioscience, Inc.

Symbol
DARE on Nasdaq
Location
San Diego, CA

Quick Takeaways

  • DARE - Dare Bioscience, Inc. has 11 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are available for direct filing-level review.

What Changed

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Why This Matters

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 02 May 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Dare Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Sabrina Martucci Johnson Chef Executive Officer, Director Mixed 18 Feb 2026
William H. Rastetter Director Mixed 09 Jul 2025
MarDee Haring-Layton Chief Accounting Officer Mixed 30 Jan 2026
Robin Joan Steele Director Mixed 09 Jul 2025
Cheryl R. Blanchard Director Mixed 21 Jun 2023
Nnenna Ononye Onyia Director Mixed 21 Jun 2023
Lisa Walters-Hoffert Chief Financial Officer Mixed 24 Jan 2023
Gregory W. Matz Director Mixed 09 Jul 2025
Jessica D. Grossman Director Mixed 09 Jul 2025
John A. Fair Chief Commercial Officer Mixed 12 Mar 2024
Susan L. Kelley Director Mixed 09 Jul 2025

Top shareholders of Dare Bioscience, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
class O/S missing
523,053
$1,009,492 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
118,655
$229,042 31 Dec 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
class O/S missing
70,021
$135,141 31 Dec 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
class O/S missing
33,036
$63,759 31 Dec 2025
13F
STATE STREET CORP
13F
Company
class O/S missing
23,515
$45,384 31 Dec 2025
13F
US BANCORP \DE\
13F
Company
class O/S missing
20,920
$40,376 31 Dec 2025
13F
UBS Group AG
13F
Company
class O/S missing
20,915
$40,366 31 Dec 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
class O/S missing
19,295
$37,239 31 Dec 2025
13F
Virtu Financial LLC
13F
Company
class O/S missing
19,200
$37,000 31 Dec 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
class O/S missing
17,900
$34,547 31 Dec 2025
13F
BlackRock, Inc.
13F
Company
class O/S missing
16,971
$32,754 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
class O/S missing
15,431
$29,782 31 Dec 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
class O/S missing
15,334
$29,595 31 Dec 2025
13F
LPL Financial LLC
13F
Company
class O/S missing
14,639
$28,253 31 Dec 2025
13F
XTX Topco Ltd
13F
Company
class O/S missing
10,983
$21,197 31 Dec 2025
13F
Objectivity Squared, LLC
13F
Company
class O/S missing
10,915
$21,066 31 Dec 2025
13F
JANE STREET GROUP, LLC
13F
Company
class O/S missing
10,559
$20,379 31 Dec 2025
13F
HRT FINANCIAL LP
13F
Company
class O/S missing
10,497
$20,000 31 Dec 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
class O/S missing
10,222
$20,000 31 Dec 2025
13F
Parallel Advisors, LLC
13F
Company
class O/S missing
2,405
$4,643 31 Dec 2025
13F
IFS Advisors, LLC
13F
Company
class O/S missing
950
$1,833 31 Dec 2025
13F
SBI Securities Co., Ltd.
13F
Company
class O/S missing
575
$1,110 31 Dec 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
129
$250 31 Dec 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
class O/S missing
110
$212 31 Dec 2025
13F
CALDWELL SUTTER CAPITAL, INC.
13F
Company
class O/S missing
17
$33 31 Dec 2025
13F
Inspire Investing, LLC
13F
Company
class O/S missing
12
$23 31 Dec 2025
13F
Cornerstone Planning Group LLC
13F
Company
class O/S missing
2
$4 31 Dec 2025
13F
John A. Fair
3/4/5
Chief Commercial Officer
class O/S missing
290,000
12 Mar 2024
Lisa Walters-Hoffert
3/4/5
Chief Financial Officer
class O/S missing
290,000
24 Jan 2023
Sabrina Martucci Johnson
3/4/5
Chef Executive Officer, Director
mixed-class rows
204,400
mixed-class rows
18 Feb 2026
MarDee Haring-Layton
3/4/5
Chief Accounting Officer
class O/S missing
49,000
30 Jan 2026
Cheryl R. Blanchard
3/4/5
Director
class O/S missing
40,000
21 Jun 2023
Nnenna Ononye Onyia
3/4/5
Director
class O/S missing
40,000
21 Jun 2023
Gregory W. Matz
3/4/5
Director
class O/S missing
4,500
09 Jul 2025
Jessica D. Grossman
3/4/5
Director
class O/S missing
4,500
09 Jul 2025
Robin Joan Steele
3/4/5
Director
class O/S missing
4,500
09 Jul 2025
Susan L. Kelley
3/4/5
Director
class O/S missing
4,500
09 Jul 2025
William H. Rastetter
3/4/5
Director
class O/S missing
4,500
09 Jul 2025
LAW CUSTODIAL INC.
13D/G
7.8%
$0 22 Dec 2025

Recent Insider Transactions by Companies or Individuals for Dare Bioscience, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Sabrina Martucci Johnson DARE Common Stock Warrant (right to buy) Award 21,600 21,600 18 Feb 2026 Direct
Sabrina Martucci Johnson DARE Series A Convertible Preferred Stock Award 10,800 10,800 18 Feb 2026 Direct
MarDee Haring-Layton DARE Employee Stock Option (right to buy) Award 49,000 49,000 30 Jan 2026 Direct
Sabrina Martucci Johnson DARE Employee Stock Option (right to buy) Award 172,000 172,000 30 Jan 2026 Direct
MarDee Haring-Layton DARE Employee Stock Option (right to buy) Award 57,000 57,000 04 Sep 2025 Direct
William H. Rastetter DARE Stock Option (right to buy) Award 4,500 4,500 09 Jul 2025 Direct
Robin Joan Steele DARE Stock Option (right to buy) Award 4,500 4,500 09 Jul 2025 Direct
Gregory W. Matz DARE Stock Option (right to buy) Award 4,500 4,500 09 Jul 2025 Direct
Jessica D. Grossman DARE Stock Option (right to buy) Award 4,500 4,500 09 Jul 2025 Direct
Susan L. Kelley DARE Stock Option (right to buy) Award 4,500 4,500 09 Jul 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .